M. Frazzoni
Divisione di Medicina Interna e Gastroenterologia
Ospedale S. Agostino
Modena
Italy
Name/email consistency: high
- Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Frazzoni, M., De Micheli, E., Zentilin, P., Savarino, V. Aliment. Pharmacol. Ther. (2004)
- Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole. Frazzoni, M., De Micheli, E., Grisendi, A., Savarino, V. Aliment. Pharmacol. Ther. (2003)
- Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Frazzoni, M., De Micheli, E., Savarino, V. Aliment. Pharmacol. Ther. (2003)
- Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison. Frazzoni, M., De Micheli, E., Grisendi, A., Savarino, V. Aliment. Pharmacol. Ther. (2002)
- Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison. Frazzoni, M., Grisendi, A., Lanzani, A., Melotti, G., De Micheli, E. Dig. Liver. Dis (2002)
- Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression. Frazzoni, M., De Micheli, E., Grisendi, A., Savarino, V. Aliment. Pharmacol. Ther. (2002)









